Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million
04/03/2026 21:01
Mar 04 (Reuters) - Aquestive Therapeutics, Inc. Q4 revenue USD 13.015 million vs. IBES estimate USD 13.3 million. Q4 pretax profit USD -31.86 million Q4 income from operations USD -28.839 million Q4 adjusted EBITDA USD -27.334 million
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Aquestive rises on US licensing deal for seizure drug with Eton Pharma